Alnylam Pharmaceuticals
ALNY
#565
Rank
โ‚น3.915 T
Marketcap
โ‚น29,638
Share price
-0.93%
Change (1 day)
21.61%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) Fails to deliver data

Key failure to deliver metrics for Alnylam Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alnylam Pharmaceuticals (ALNY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alnylam Pharmaceuticals (ALNY) - since 2013

Volume in USD (price x number of shares), data since 2013

Alnylam Pharmaceuticals (ALNY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚น0 M-99.99%
2025โ‚น42.8 M-0.86%
2024โ‚น43.18 M-16.96%
2023โ‚น51.99 M-66.55%
2022โ‚น0.15 B200.46%
2021โ‚น51.74 M-9.83%
2020โ‚น57.38 M52.34%
2019โ‚น37.66 M46.52%
2018โ‚น25.7 M-70.97%
2017โ‚น88.54 M191.96%
2016โ‚น30.32 M-14.94%
2015โ‚น35.65 M68.07%
2014โ‚น21.21 M152.1%
2013โ‚น8.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Novartis
NVS
โ‚น93.01 Mโ‚น0.15 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น10.89 Mโ‚น69.64 M๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
โ‚น4.5 Mโ‚น68.25 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น3.82 Mโ‚น21.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
N/Aโ‚น5.34 M๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น0.11 Mโ‚น7.23 M๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น53.08 Mโ‚น87.14 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
โ‚น3.87 Mโ‚น10.57 M๐Ÿ‡บ๐Ÿ‡ธ USA